FULL DETAILS (Read-only)  -> Click Here to Create PDF for Current Dataset of Trial
CTRI Number  CTRI/2021/02/030952 [Registered on: 03/02/2021] Trial Registered Prospectively
Last Modified On: 02/02/2021
Post Graduate Thesis  Yes 
Type of Trial  Interventional 
Type of Study   Other (Specify) [Topical chemical peel]  
Study Design  Randomized, Parallel Group Trial 
Public Title of Study   Study to compare the effectiveness of 15% trichloroacetic acid peel and 35% glycolic acid peel in the treatment of acanthosis nigricans 
Scientific Title of Study   Efficacy of 15% trichloroacetic acid peel versus 35% glycolic acid peel in acanthosis nigricans - a randomized open label study 
Trial Acronym   
Secondary IDs if Any  
Secondary ID  Identifier 
NIL  NIL 
 
Details of Principal Investigator or overall Trial Coordinator (multi-center study)  
Name  Bharati 
Designation  First Year Post Graduate Resident Department of Dermatology and STD 
Affiliation  Lady Hardinge Medical College  
Address  Duty Doctor Room Dermatology Ward, Department of Dermatology and STD, Lady Hardinge Medical College Shaheed Bhagat Singh Marg, Delhi
Duty Doctor Room Dermatology Ward, Department of Dermatology and STD,Lady Hardinge Medical College Shaheed Bhagat Singh Marg, Delhi
Central
DELHI
110001
India 
Phone  9953493348  
Fax    
Email  bharati2002@gmail.com  
 
Details of Contact Person
Scientific Query
 
Name  Rashmi Sarkar 
Designation  Professor Department of Dermatology and STD 
Affiliation  Lady Hardinge Medical College  
Address  Library, First Floor Old Building Lady Hardinge Medical College Shaheed Bhagat Singh, Delhi
Library, First Floor Old Building Lady Hardinge Medical College Shaheed Bhagat Singh, Delhi
Central
DELHI
110001
India 
Phone  9818244340  
Fax    
Email  rashmisarkar@gmail.com  
 
Details of Contact Person
Public Query
 
Name  Rashmi Sarkar 
Designation  Professor Department of Dermatology and STD 
Affiliation  Lady Hardinge Medical College  
Address  Library, First Floor Old Building Lady Hardinge Medical College Shaheed Bhagat Singh Marg, Delhi
Library, First Floor Old Building Lady Hardinge Medical College Shaheed Bhagat Singh Marg, Delhi
Central
DELHI
110001
India 
Phone  9818244340  
Fax    
Email  rashmisarkar@gmail.com  
 
Source of Monetary or Material Support  
Lady Hardinge Medical College, Shaheed Bhagat Singh Marg, New Delhi  
 
Primary Sponsor  
Name  Lady Hardinge Medical College  
Address  Lady Hardinge Medical College Shaheed Bhagat Singh Marg, Delhi - 110001 
Type of Sponsor  Government medical college 
 
Details of Secondary Sponsor  
Name  Address 
NIL  NIL 
 
Countries of Recruitment     India  
Sites of Study  
No of Sites = 1  
Name of Principal Investigator  Name of Site  Site Address  Phone/Fax/Email 
Bharati  Lady Hardinge Medical College   Room Number 6B, Out Patient Department, Department of Dermatology and STD, Smt Sucheta Kriplani Hospital, Lady Hardinge Medical College Shaheed Bhagat Singh Marg, New Delhi
Central
DELHI 
9953493348

bharati2002@gmail.com 
 
Details of Ethics Committee  
No of Ethics Committees= 1  
Name of Committee  Approval Status 
Institutional Ethics Committee Lady Hardinge Medical College and Associated Hospitals, Shahid Bhagat Singh Marg, New Delhi 110001, India  Approved 
 
Regulatory Clearance Status from DCGI  
Status 
Not Applicable 
 
Health Condition / Problems Studied  
Health Type  Condition 
Patients  (1) ICD-10 Condition: L83||Acanthosis nigricans,  
 
Intervention / Comparator Agent  
Type  Name  Details 
Intervention  Chemical Peel  15% Trichloroacetic Acid Peel will be used in group A. Peel is topically applied. 3 setting of peeling will be done at the interval of 2 weeks 
Intervention  Chemical Peel  35% Glycolic Acid Peel will be given in group B. Peel is topically applied. 3 settings of peeling will be done at the interval of 2 weeks 
Comparator Agent  Nil  Nil 
 
Inclusion Criteria  
Age From  18.00 Year(s)
Age To  70.00 Year(s)
Gender  Both 
Details  All adult population in the age group of 18 years and above with clinical diagnosis of acanthosis nigricans involving face or neck or elbow or any combination of these three presenting to dermatology outpatient department at Smt Sucheta Kriplani Hospital  
 
ExclusionCriteria 
Details  ∙ Pregnant and lactating females.
∙ Hypersensitivity to peeling agent.
∙ Skin infection at the site of acanthosis nigricans ( Herpes, pyoderma, folliculitis) ∙ Individual prone to keloid formation
∙ History of any topical application in last 4 weeks
 
 
Method of Generating Random Sequence   Computer generated randomization 
Method of Concealment   Sequentially numbered, sealed, opaque envelopes 
Blinding/Masking   Open Label 
Primary Outcome  
Outcome  TimePoints 
∙ Proportion of patients with Physician Assessment Score (PAS) more than 2 in the two groups. ∙ Improvement in mean ANASI Score in two groups.   At baseline, 2, 4, 6, 8 weeks 
 
Secondary Outcome  
Outcome  TimePoints 
∙ Mean Patient Satisfaction Score after 3 sessions in the two groups.   4,6,8 weeks 
∙ Proportion of patients experiencing adverse effects in two groups.   4, 6, 8 weeks 
 
Target Sample Size   Total Sample Size="40"
Sample Size from India="40" 
Final Enrollment numbers achieved (Total)= "Applicable only for Completed/Terminated trials"
Final Enrollment numbers achieved (India)="Applicable only for Completed/Terminated trials" 
Phase of Trial   N/A 
Date of First Enrollment (India)   05/02/2021 
Date of Study Completion (India) Applicable only for Completed/Terminated trials 
Date of First Enrollment (Global)  Date Missing 
Date of Study Completion (Global) Applicable only for Completed/Terminated trials 
Estimated Duration of Trial   Years="1"
Months="5"
Days="0" 
Recruitment Status of Trial (Global)   Not Applicable 
Recruitment Status of Trial (India)  Not Yet Recruiting 
Publication Details   Results will be published in a scientific journal  
Individual Participant Data (IPD) Sharing Statement

Will individual participant data (IPD) be shared publicly (including data dictionaries)?  

Response - NO
Brief Summary  
Acanthosis nigricans is the disorder in which the skin becomes darkened, thickened and velvety in textured. It is quite distressful for the patient. Very few studies are available which have documented the efficacy of various treatment options for the same. Therefore the aim of the study is to observe the efficacy of the treatment options routinely offered to the patient with acanthosis nigricans. 
There will be two group of patients, one will receive 15% trichloroacetic acid peel and other will receive 35% glycolic acid peel. Patients will be randomly allocated in one of the group. 3 sessions of peeling will be performed at an interval of 2 weeks.     Following observations will be made.  
1. Proportion of patients with Physician Assessment Score more than 2 in the two groups.
2. Improvement in mean ANASI score in two groups.
3. Mean Patient Satisfaction Score after 3 session in the two groups.
4. Proportion of patients experiencing adverse effects in two groups.

Data will be analyzed using freely available analytical software.                                                                                   
 
Close